NantKwest Backtesting

NantKwest Inc -- USA Stock  

USD 4.49  0.11  2.39%

With this equity back-testing module your can estimate the performance of a buy and hold strategy of NantKwest Inc and determine expected loss or profit from investing in NantKwest over given investment horizon. Please see also NantKwest Hype Analysis, NantKwest Correlation, NantKwest Valuation, NantKwest Volatility as well as analyze NantKwest Alpha and Beta and NantKwest Performance
Investment Horizon     30 Days    Login   to change

NantKwest 'What if' Analysis

September 18, 2017
No Change 0.00  0.0%
In 31 days
October 18, 2017
If you would invest  0.00  in NantKwest on September 18, 2017 and sell it all today you would earn a total of 0.00 from holding NantKwest Inc or generate 0.0% return on investment in NantKwest over 30 days. NantKwest is related to or competes with Del Mar, Dimension Therapeutics, VBI Vaccines, Vascular Biogenics, and Vericel. NantKwest Incs product candidates include activated natural killer candidates for the treatment of virallyinduced cancer...

NantKwest Upside/Downside Indicators


NantKwest Market Premium Indicators

NantKwest Inc lagged returns against current returns

 Current and Lagged Values 

NantKwest regressed lagged prices vs. current prices

 Current vs Lagged Prices 

NantKwest Inc Backtested Returns

Macroaxis considers NantKwest to be not very volatile. NantKwest Inc has Sharpe Ratio of -0.4765 which conveys that NantKwest Inc had -0.4765% of return per unit of risk over the last 1 month. Macroaxis philosophy towards estimating risk of any stock is to look at both systematic and un-systematic factors of the business, including all available market data and technical indicators. NantKwest exposes twenty-one different technical indicators which can help you to evaluate volatility that cannot be diversified away. Please be advised to verify NantKwest Inc Mean Deviation of 1.74 and Risk Adjusted Performance of (0.096754) to check out risk estimate we provide. Macroaxis gives NantKwest performance score of 0 on a scale of 0 to 100. The company secures Beta (Market Risk) of -5.7146 which conveys that as returns on market increase, returns on owning NantKwest are expected to decrease by larger amounts. On the other hand, during market turmoil, NantKwest is expected to significantly outperform it.. Even though it is essential to pay attention to NantKwest Inc price patterns, it is always good to be careful when utilizing equity historical price patterns. Macroaxis philosophy towards estimating future performance of any stock is to check both, its past performance charts as well as the business as a whole, including all available technical indicators. NantKwest exposes twenty-one different technical indicators which can help you to evaluate its performance. NantKwest Inc has expected return of -1.0964%. Please be advised to verify NantKwest Inc Standard Deviation, Maximum Drawdown as well as the relationship between Maximum Drawdown and Expected Short fall to decide if NantKwest Inc past performance will be repeated at some point in the near future.
Advice Volatility Trend Exposure Correlations
15 days auto-correlation 0.47 

Average predictability

NantKwest Inc has average predictability. Overlapping area represents the amount of predictability between NantKwest time series from September 18, 2017 to October 3, 2017 and October 3, 2017 to October 18, 2017. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of NantKwest Inc price movement. The serial correlation of 0.47 indicates that about 47.0% of current NantKwest price fluctuation can be explain by its past prices.
Correlation Coefficient 0.47
Spearman Rank Test 0.29
Price Variance 0.08
Lagged Price Variance 0.02

NantKwest Lagged Returns

 Regressed Prices 

NantKwest Performance vs DOW

The median price of NantKwest for the period between Mon, Sep 18, 2017 and Wed, Oct 18, 2017 is 5.41 with a coefficient of variation of 6.81. The daily time series for the period is distributed with a sample standard deviation of 0.36, arithmetic mean of 5.23, and mean deviation of 0.3. The Stock received some media coverage during the period.
Price Growth (%)  
NantKwest, Inc. Downgraded by Zacks Investment Research10/18/2017